Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis
Authors
Keywords
Hemorrhage, Thromboembolism, Meta-analysis, Atrial fibrillation, Heparin, Ischemic stroke, Database searching, Vitamin K
Journal
PLoS One
Volume 10, Issue 5, Pages e0126512
Publisher
Public Library of Science (PLoS)
Online
2015-05-15
DOI
10.1371/journal.pone.0126512
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Safety of Left Atrial Catheter Ablation Procedures for Atrial Arrhythmias Under Continuous Anticoagulation With Apixaban Versus Phenprocoumon
- (2015) Bernhard M. Kaess et al. AMERICAN JOURNAL OF CARDIOLOGY
- Meta-Analysis of Risk of Stroke or Transient Ischemic Attack With Dabigatran for Atrial Fibrillation Ablation
- (2014) Partha Sardar et al. AMERICAN JOURNAL OF CARDIOLOGY
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management
- (2014) Luigi Di Biase et al. CIRCULATION
- Safety of Continuous Periprocedural Rivaroxaban for Patients Undergoing Left Atrial Catheter Ablation Procedures
- (2014) Roger Dillier et al. Circulation-Arrhythmia and Electrophysiology
- Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation
- (2014) R. Providencia et al. EUROPACE
- Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
- (2014) R. A. Winkle et al. EUROPACE
- Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark
- (2014) Deniz Karasoy et al. EUROPEAN HEART JOURNAL
- Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation
- (2014) Gevorg Stepanyan et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Intracoronary Versus Intravenous Abciximab Bolus Administration
- (2014) Salvatore De Rosa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparative Safety of Periablation Anticoagulation Strategies for Atrial Fibrillation: Data from a Large Multicenter Study
- (2014) AYSHA ARSHAD et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis
- (2013) Mohammed Shurrab et al. CANADIAN JOURNAL OF CARDIOLOGY
- Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
- (2013) Mohamed Bassiouny et al. Circulation-Arrhythmia and Electrophysiology
- Usefulness of Dabigatran Etexilate as Periprocedural Anticoagulation Therapy for Atrial Fibrillation Ablation
- (2013) Hirosuke Yamaji et al. CLINICAL DRUG INVESTIGATION
- Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature
- (2013) Stefan H. Hohnloser et al. EUROPACE
- Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis
- (2013) Rui Providência et al. HEART
- Left radial access for percutaneous coronary procedures: From neglected to performer? A meta-analysis of 14 studies including 7603 procedures
- (2013) Salvatore De Rosa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Dabigatran versus Warfarin Therapy for Uninterrupted Oral Anticoagulation During Atrial Fibrillation Ablation
- (2013) WILLIAM MADDOX et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation
- (2013) David E. Haines et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter
- (2013) Daniel W. Kaiser et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay
- (2013) Kimitake Imamura et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
- (2013) Jonathan P. Piccini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- COMPARISON OF ATRIAL FIBRILLATION ABLATION BLEEDING AND THROMBOTIC COMPLICATIONS WITH DABIGATRAN, RIVAROXABAN AND WARFARIN
- (2013) Michael Bernard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Periprocedural Dabigatran in Patients Undergoing Catheter Ablation of Atrial Fibrillation
- (2012) Kenichi Kaseno et al. CIRCULATION JOURNAL
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation
- (2012) Jin-Seok Kim et al. HEART RHYTHM
- Intracoronary abciximab reduces death and major adverse cardiovascular events in acute coronary syndromes: A meta-analysis of clinical trials
- (2012) Salvatore De Rosa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A comparison of bleeding complications post-ablation between warfarin and dabigatran
- (2012) David Snipelisky et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin
- (2012) Sai V. Konduru et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
- (2012) Dhanunjaya Lakkireddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Controlled Trial of Dabigatran versus Warfarin for Periablation Anticoagulation in Patients Undergoing Ablation of Atrial Fibrillation
- (2012) TAKAMITSU NIN et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart Disease and Stroke Statistics—2009 Update
- (2009) et al. CIRCULATION
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started